We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Cephalon (MM) | NASDAQ:CEPH | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 81.49 | 0 | 00:00:00 |
From Dec 2019 to Dec 2024
Teva Pharmaceutical Industries Ltd. (TEVA) is poised to receive conditional clearance from the European Union for its almost $7 billion takeover of U.S. specialty drugmaker Cephalon Inc. (CEPH), Reuters reported Monday citing a person with direct knowledge of the matter.
The EU executive, which is scheduled to decide by Oct. 13 whether to clear the acquisition, wasn't immediately available for comment, Reuters said.
Full story at http://www.reuters.com/article/2011/10/10/us-cephalon-teva-eu-idUSTRE7993OH20111010
-Dow Jones Newswires; 212-416-2900
1 Year Cephalon Chart |
1 Month Cephalon Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
